Meta Pixel

News and Announcements

SkyBuys champions contactless transactions in duty free.

  • Published June 15, 2020 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates
The COVID-19 pandemic has impacted almost every aspect of aviation, and when international flights resume, passengers can expect a number of significant changes.

As part of this “new norm”, as travel restrictions are removed, the SkyBuys platform and app will provide passengers with a powerful digital and contactless transaction solution when they shop for duty free during their travels.

And Sydney Airport is forecast to be the busiest international airport in the region. Working with the airport’s concessionaire Heinemann, SkyBuys will ramp up marketing with a variety of offers through its app.

Lockdown has provided SkyBuys with the opportunity to progress its Airbus project, where the world’s leading aircraft manufacturer with over 150 airline clients, now have already demonstrated the application to airline customers.

SkyBuys will continue to work with Airbus as the SkyPaas project moves from testing to live application. Additionally, SkyBuys has secured trial projects with a number of world leading brands, as well as a number of additional retail projects and has also secured a revenue-share agreement in the US with the global travel industry’s leading market research group.

About SkyBuys
Addressing a $75billion global duty-free market, early-stage technology company SkyBuys is improving travel retail. SkyBuys provides convenience, value and choice to international passengers, and new business opportunities to airlines, travel retailers and brand managers. SkyBuys delivered the PoC for its online platform and app with Airbus in Hamburg and is now working with Heinemann at Sydney Airport.

Company Updates

View All
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula
Capital Insights
The Algorithm Re-Dosing Cancer Treatment: Inside the University of Melbourne Spin-Out Rewriting a 60-Year-Old Formula

Oncology specialists are still calculating toxic chemotherapy doses using a formula from the era of the Ford Model T, leading to a system where seven out of eight patients are routinely overdosed. University of Melbourne spin-out PredicTx is dismantling this legacy approach, utilizing advanced AI to analyze existing patient CT scans, deliver precision medicine to the bedside, and return a massive 100x financial rerate to hospital networks.

Read more
View All

Join over 45,000+ sophisticated investors

Join Now